Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$79K

Rothblatt Martine A Chairperson & CEO

Transaction date Sep 23, 2026
Public filing date Sep 24, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$489.42 Sep 23, 2026
First close after public filing
$475.45 Sep 25, 2026
30-day return after filing
+24.69% Through Oct 26, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
160 shares @ $493.72
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000148
Filing cohort

Transactions in this filing

Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$5.79M
Buys / sales
0 / 12
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Current Sale Sep 23, 2026 $79K
United Therapeutics Corp UTHR Sale Sep 23, 2026 $76.75K
United Therapeutics Corp UTHR Sale Sep 23, 2026 $260.6K
United Therapeutics Corp UTHR Sale Sep 23, 2026 $380.91K
United Therapeutics Corp UTHR Sale Sep 23, 2026 $134.56K
United Therapeutics Corp UTHR Sale Sep 23, 2026 $44.9K
United Therapeutics Corp UTHR Sale Sep 23, 2026 $120.01K
United Therapeutics Corp UTHR Exercise Sep 23, 2026 $0
United Therapeutics Corp UTHR Exercise Sep 23, 2026 $1.12M
United Therapeutics Corp UTHR Sale Sep 23, 2026 $1.17M
United Therapeutics Corp UTHR Sale Sep 23, 2026 $405.12K
United Therapeutics Corp UTHR Sale Sep 23, 2026 $1.06M
United Therapeutics Corp UTHR Sale Sep 23, 2026 $706.29K
United Therapeutics Corp UTHR Sale Sep 23, 2026 $236.42K